MAURIZI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 772
EU - Europa 543
AS - Asia 154
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 1.473
Nazione #
US - Stati Uniti d'America 770
IE - Irlanda 193
IT - Italia 108
CN - Cina 90
DE - Germania 68
SE - Svezia 63
TR - Turchia 33
UA - Ucraina 33
GB - Regno Unito 31
FI - Finlandia 15
VN - Vietnam 14
SG - Singapore 9
CZ - Repubblica Ceca 8
FR - Francia 7
BE - Belgio 4
IN - India 4
RU - Federazione Russa 4
ES - Italia 3
EU - Europa 3
AT - Austria 2
NL - Olanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CA - Canada 1
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
PR - Porto Rico 1
TW - Taiwan 1
Totale 1.473
Città #
Chandler 221
Dublin 191
Jacksonville 106
Boardman 38
Ann Arbor 33
Ashburn 33
New York 30
Lawrence 28
Princeton 28
L'aquila 25
Izmir 23
Wilmington 23
Kitzingen 21
Nanjing 20
Dong Ket 14
Rome 14
San Mateo 12
Beijing 11
Falls Church 11
Nanchang 10
Kunming 9
Milan 9
Shanghai 9
Woodbridge 9
Brno 8
Bremen 7
Seattle 7
Aquila 6
Dearborn 6
Norwalk 6
West Jordan 6
Helsinki 5
Singapore 5
Brussels 4
Cologne 4
Hebei 4
Jiaxing 4
L’Aquila 4
Mountain View 4
Munich 4
Verona 4
Washington 4
Des Moines 3
Fremont 3
Jinan 3
Lappeenranta 3
Los Angeles 3
Moscow 3
Tianjin 3
Amsterdam 2
Hanover 2
Lanzhou 2
London 2
Monserrato 2
Nerviano 2
Ningbo 2
Paganica 2
Pisa 2
Pune 2
Regensburg 2
Shenyang 2
Vienna 2
Zhengzhou 2
Barcelona 1
Boscotrecase 1
Casal di Principe 1
Chicago 1
Cividate al Piano 1
Cochabamba 1
Cologno Monzese 1
Dallas 1
Dubai 1
Edinburgh 1
Galliate 1
Gandhi Nagar 1
Guiyang 1
Haikou 1
Hangzhou 1
Harbin 1
Houston 1
Istanbul 1
Leipzig 1
Macao 1
Madrid 1
Modena 1
Montreal 1
Mumbai 1
Noisy-le-grand 1
Pescara 1
Piera 1
Poli 1
Redmond 1
Redwood City 1
San Giovanni 1
San Juan 1
San Vito Chietino 1
Santa Clara 1
Secaucus 1
Stockholm 1
Strasbourg 1
Totale 1.106
Nome #
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) 140
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 98
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 83
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 79
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 78
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 76
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 75
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 71
The Great Beauty of the osteoclast 68
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 68
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 53
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 50
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 49
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 45
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 44
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 43
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 41
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 39
The osteoclast in bone metastasis: Player and target 38
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 33
A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders 31
How the "seed" prepares the "soil": The bone/bone marrow pre-metastatic niche 31
Osteopetrosis 30
Role of Neural (N)-Cadherin in Breast Cancer Cell Stemness and Dormancy in the Bone Microenvironment 29
Reprint of: The Great Beauty of the osteoclast 28
MC4R-dependent suppression of appetite by bone-derived lipocalin 2 28
Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation 22
Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta 19
A mutation in the ZNF687 gene that is responsible for the severe form of Paget's disease of bone causes severely altered bone remodeling and promotes hepatocellular carcinoma onset in a knock-in mouse model 9
Therapeutic compounds and compositions 6
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 6
Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans 6
High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench 4
Experimental therapies for osteopetrosis 4
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology 3
Phenotype of the first mouse model of Cole Carpenter Syndrome. 2
Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background 2
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 2
A perspective on muscle phenotyping in musculoskeletal research 1
Totale 1.534
Categoria #
all - tutte 6.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020168 22 8 12 3 3 35 38 0 14 11 4 18
2020/2021169 2 22 1 17 15 7 17 8 24 9 25 22
2021/2022163 7 3 30 10 7 9 6 16 21 9 9 36
2022/2023585 34 42 4 77 49 52 1 54 245 2 24 1
2023/2024229 17 16 16 7 20 60 3 1 6 11 6 66
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 1.534